Lipoprotein(a) and the estimation of low-density cholesterol by the formula of Friedewald: A new problem for an old equation;Lipoproteína(a) y estimación del colesterol LDL mediante la fórmula de Friedewald: Un nuevo problema para una vieja ecuación

Medicina Clinica

Volumn 113, Issue 8, 1999, Pages 290-291

  Hernández, Cristina ^a   Chacón, Pilar ^a   Garcícia Pascual, Luis ^b   Rosselló, José ^a   Simó, Rafael ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Friedewald's formula; LDL cholesterol; Lipoprotein(a)

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD; ENZYME ASSAY; HUMAN; METHODOLOGY; RETROSPECTIVE STUDY;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENZYME TESTS; HUMANS; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0033581238     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
2. Seeman LJ, Jenner JL, McNamara JR, Schaefer EJ. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin Chem 1994; 40: 400-403.
3. Maher VMG, Brown BG. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 1995; 6: 229-235.
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), I: classification, prevalence, detection and evaluation. Circulation 1994; 89: 1.344-1.366, 1.432-1.445.
5. Manninen V. Clinical results with gemfibrozil and background for the Helsinky Heart Study. Am J Cardiol 1983: 52: 35-38.
6. Ooi TC, Heinonen T, Alaupovic P. Davignon J, Leiter L, Lupien PJ et al. Efficacy and safety of a new hydroxymethylglutaryl-coenzime A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate. Artherioscl Thromb Vase Biol 1997; 17: 1.793-1.799.
7. Boerwinkle E. Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipopprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
8. Senti M, Pedro-Botet J, Nogués X, Rubiés-Prat J. Influence of intermediate-density lipoproteins on the accuracy of the Freidewald formula. Clin Chem 1991; 37: 1.394-1.397.
9. Mata C, Cabré M, La Ville A, Prats E, Joven J, Turner PR et al. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem 1994; 40: 404-406.
10. Warnick GR. Lp(a) is included in low-density lipoprotein by NCEP definition. Clin Chem 1994; 40:2.115-2.116.